Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologistsMargaret Ottaviano, Vincenzo Montesarchio, Marcello Curvietto et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 19
Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trialAlexander M.M. Eggermont, Alessandro Testori, Peter Dziewulski et al.|European Journal of Cancer|2020Cited by 14